Acumen Pharmaceuticals Inc. Made Headway
Wed, Sep 28, 2022 at 07:40 PM
Acumen Pharmaceuticals Inc. (ABOS:NASDAQ) rocketted at $9.58, a gain of 103.8%. On Wed, Sep 28, 2022, ABOS:NASDAQ hit a New 2-Week High of $9.58. The stock appeared on our News Catalysts scanner on Thu, Sep 08, 2022 at 01:26 PM in the 'MISCELLANEOUS' category. From Wed, Sep 14, 2022, the stock recorded 30.00% Up Days and 45.45% Green Days
About Acumen Pharmaceuticals Inc. (ABOS:NASDAQ)
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what we believe to be a key underlying cause of Alzheimer's disease.
Top 10 Gainers:
- Acumen Pharmaceuticals Inc. (ABOS:NASDAQ), 103.83%
- Prothena Corporation plc (PRTA:NASDAQ), 87.52%
- BTRS Holdings Inc. (BTRS:NASDAQ), 60.83%
- Biogen Inc. (BIIB:NASDAQ), 39.85%
- bioAffinity Technologies Inc. (BIAF:NASDAQ), 37.74%
- Missfresh Limited (MF:NASDAQ), 34.88%
- KLX Energy Services Holdings, Inc. (KLXE:NASDAQ), 30.28%
- Top Ships Inc. (TOPS:NASDAQ), 29.49%
- Manitex International, Inc. (MNTX:NASDAQ), 29.25%
- Quanterix Corporation (QTRX:NASDAQ), 29.16%